Idiopathic hypereosinophilic syndrome.
Idiopathic hypereosinophilic syndrome is a rare but clearly defined cause of peripheral eosinophilia. The cardiovascular and hematopoietic systems are most severely affected. The clinical manifestations are a result of eosinophilic infiltration into tissues, release of eosinophilic products, and induction of a hypercoagulable state. Treatment is aimed at reducing absolute numbers of eosinophils to prevent tissue damage and halt progression of the disease.
Jameson
M D
MD
Department of Medicine, University of Kansas Medical Center, Kansas City.
Segraves
S D
SD
D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013577:Syndrome
D011241:Prednisone